Françoise Morin

1.6k total citations
50 papers, 1.2k citations indexed

About

Françoise Morin is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Françoise Morin has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 14 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Françoise Morin's work include Alzheimer's disease research and treatments (17 papers), Neuroscience and Neuropharmacology Research (11 papers) and Tryptophan and brain disorders (5 papers). Françoise Morin is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Neuroscience and Neuropharmacology Research (11 papers) and Tryptophan and brain disorders (5 papers). Françoise Morin collaborates with scholars based in Canada, France and United States. Françoise Morin's co-authors include Emmanuel Planel, Robert A. Whittington, Franck R. Petry, Sébastien S. Hébert, Frédéric Calon, Maud Gratuze, Carl Julien, François Marcouiller, Noura B. El Khoury and Marie-Amélie Papon and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cell and The Journal of Immunology.

In The Last Decade

Françoise Morin

45 papers receiving 1.2k citations

Peers

Françoise Morin
Françoise Morin
Citations per year, relative to Françoise Morin Françoise Morin (= 1×) peers Friederike Hörster

Countries citing papers authored by Françoise Morin

Since Specialization
Citations

This map shows the geographic impact of Françoise Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Morin more than expected).

Fields of papers citing papers by Françoise Morin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Morin. The network helps show where Françoise Morin may publish in the future.

Co-authorship network of co-authors of Françoise Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Morin. A scholar is included among the top collaborators of Françoise Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Morin. Françoise Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Canet, Geoffrey, Charleine Zussy, Françoise Morin, et al.. (2025). Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models. British Journal of Pharmacology. 182(9). 1930–1956.
2.
Canet, Geoffrey, Maud Gratuze, Charleine Zussy, et al.. (2024). Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice. Neurobiology of Disease. 198. 106526–106526. 1 indexed citations
3.
Joly, Sandrine, et al.. (2022). B cell-dependent EAE induces visual deficits in the mouse with similarities to human autoimmune demyelinating diseases. Journal of Neuroinflammation. 19(1). 54–54. 7 indexed citations
4.
Canet, Geoffrey, Françoise Morin, Robert A. Whittington, et al.. (2022). Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia. Neurobiology of Aging. 113. 118–130. 9 indexed citations
5.
Gratuze, Maud, Franck R. Petry, Isabelle Poitras, et al.. (2019). The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice. Brain Research. 1711. 106–114. 8 indexed citations
6.
Hamoudi, Dounia, Laetitia Marcadet, Françoise Morin, et al.. (2018). Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy. Current Osteoporosis Reports. 16(5). 541–553. 27 indexed citations
7.
Gratuze, Maud, et al.. (2017). Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology. Scientific Reports. 7(1). 46359–46359. 58 indexed citations
8.
Gratuze, Maud, et al.. (2017). Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 79(Pt B). 452–461. 23 indexed citations
9.
Gratuze, Maud, Noura B. El Khoury, Carl Julien, et al.. (2016). Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease. Neurobiology of Disease. 98. 1–8. 36 indexed citations
10.
Gratuze, Maud, Françoise Morin, Frédéric Calon, et al.. (2016). High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology. Neurobiology of Aging. 47. 71–73. 20 indexed citations
11.
Smith, Pascal Y., Julia Hernandez-Rapp, Cynthia Lecours, et al.. (2015). miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregationin vivo. Human Molecular Genetics. 24(23). 6721–6735. 189 indexed citations
12.
Whittington, Robert A., László Virág, Maud Gratuze, et al.. (2015). Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro. Neurobiology of Aging. 36(8). 2414–2428. 30 indexed citations
13.
Noël, Anastasia, Isabelle Poitras, Franck R. Petry, et al.. (2014). ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro. Neurobiology of Aging. 36(2). 901–902. 12 indexed citations
14.
Petry, Franck R., Alexis Bretteville, Françoise Morin, et al.. (2014). Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions. PLoS ONE. 9(5). e94251–e94251. 109 indexed citations
15.
Whittington, Robert A., Alexis Bretteville, László Virág, et al.. (2013). Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation. Scientific Reports. 3(1). 1388–1388. 27 indexed citations
16.
Lessard, Frédéric, Françoise Morin, Stacey Ivanchuk, et al.. (2010). The ARF Tumor Suppressor Controls Ribosome Biogenesis by Regulating the RNA Polymerase I Transcription Factor TTF-I. Molecular Cell. 38(4). 539–550. 75 indexed citations
17.
Moutereau, Stéphane, Alexandra Dürr, Pierre Krystkowiak, et al.. (2009). Neuroendocrine Disturbances in Huntington's Disease. PLoS ONE. 4(3). e4962–e4962. 103 indexed citations
18.
Mazoyer, E., Philippe Bonnin, Martine Raphaël, et al.. (2004). Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 51(7). 672–679. 16 indexed citations
19.
Soria, J.C., Marianne Kambouchner, Françoise Morin, et al.. (2003). Long-Term Survival of Patients Given Hormonal Therapy for Metastatic Endometrial Stromal Sarcoma. Medical Oncology. 20(1). 87–94. 77 indexed citations
20.
Bonnin, Philippe, et al.. (2003). Étude des effets directs et indirects de l’érythropoïétine dans un modèle expérimental de thrombose et de saignement chez le lapin. Annales Françaises d Anesthésie et de Réanimation. 22(10). 870–878. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026